Literature DB >> 27771726

Gram-Negative Pneumonia Alters Large-Vein Cell-Adhesion Molecule Profile and Potentiates Experimental Stasis Venous Thrombosis.

Andrea T Obi1, Elizabeth Andraska, Yogendra Kanthi, Catherine E Luke, Megan Elfline, Suresh Madathilparambil, Teruna J Siahaan, Farouc A Jaffer, Thomas W Wakefield, Krishnan Raghavendran, Peter K Henke.   

Abstract

BACKGROUND/AIMS: Pneumonia is a significant risk factor for the development of venous thrombosis (VT). Cell-adhesion molecules (CAMs) are linked to the pathogenesis of both pneumonia and VT. We hypothesized that remote infection would confer a prothrombogenic milieu via systemic elevation of CAMs.
METHODS: Lung injury was induced in wild-type (C57BL/6) mice by lung contusion or intratracheal inoculation with Klebsiella pneumoniae or saline controls. K. pneumoniae-treated mice and controls additionally underwent inferior vena cava (IVC) ligation to generate VT.
RESULTS: Lung-contusion mice demonstrated no increase in E-selectin or P-selectin whereas mice infected with K. pneumoniae demonstrated increased circulating P-selectin, ICAM-1, VCAM-1 and thrombin-antithrombin (TAT) complexes. Mice with pneumonia formed VT 3 times larger than controls, demonstrated significantly more upregulation of vein-wall and systemic CAMs, and formed erythrocyte-rich thrombi.
CONCLUSION: Elevated CAM expression was identified in mice with pneumonia, but not lung contusion, indicating that the type of inflammatory stimulus and the presence of infection drive the vein-wall response. Elevation of CAMs was associated with amplified VT and may represent an alternate mechanism by which to target the prevention of VT.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27771726      PMCID: PMC5428541          DOI: 10.1159/000447299

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  52 in total

1.  Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury.

Authors:  Lorraine B Ware; Eric Camerer; Karen Welty-Wolf; Marcus J Schultz; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-04-28       Impact factor: 5.464

2.  Factor XIII activity mediates red blood cell retention in venous thrombi.

Authors:  Maria M Aleman; James R Byrnes; Jian-Guo Wang; Reginald Tran; Wilbur A Lam; Jorge Di Paola; Nigel Mackman; Jay L Degen; Matthew J Flick; Alisa S Wolberg
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

3.  Improved survival in mice given systemic gene therapy in a gram negative pneumonia model.

Authors:  Mark R Hemmila; Ming-Hui Fan; Jiyoun Kim; Jian M Sun; Lars Steinstraesser; Ke Q Gong; Saman Arbabi; Rebecca M Minter; Daniel G Remick; Grace L Su; Stewart C Wang
Journal:  J Trauma       Date:  2005-06

4.  Neutrophil extracellular traps promote deep vein thrombosis in mice.

Authors:  A Brill; T A Fuchs; A S Savchenko; G M Thomas; K Martinod; S F De Meyer; A A Bhandari; Denisa D Wagner
Journal:  J Thromb Haemost       Date:  2012-01       Impact factor: 5.824

5.  Host susceptibility to gram-negative pneumonia after lung contusion.

Authors:  Vladislav A Dolgachev; Bi Yu; Julia M Reinke; Krishnan Raghavendran; Mark R Hemmila
Journal:  J Trauma Acute Care Surg       Date:  2012-03       Impact factor: 3.313

6.  Validation of the Caprini Venous Thromboembolism Risk Assessment Model in Critically Ill Surgical Patients.

Authors:  Andrea T Obi; Christopher J Pannucci; Andrew Nackashi; Newaj Abdullah; Rafael Alvarez; Vinita Bahl; Thomas W Wakefield; Peter K Henke
Journal:  JAMA Surg       Date:  2015-10       Impact factor: 14.766

Review 7.  Inflammation, endothelium, and coagulation in sepsis.

Authors:  Marcel Schouten; Willem Joost Wiersinga; Marcel Levi; Tom van der Poll
Journal:  J Leukoc Biol       Date:  2007-11-21       Impact factor: 4.962

Review 8.  The discovery, biology, and drug development of sialyl Lea and sialyl Lex.

Authors:  John L Magnani
Journal:  Arch Biochem Biophys       Date:  2004-06-15       Impact factor: 4.013

9.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.

Authors:  Marie-Luise von Brühl; Konstantin Stark; Alexander Steinhart; Sue Chandraratne; Ildiko Konrad; Michael Lorenz; Alexander Khandoga; Anca Tirniceriu; Raffaele Coletti; Maria Köllnberger; Robert A Byrne; Iina Laitinen; Axel Walch; Alexander Brill; Susanne Pfeiler; Davit Manukyan; Siegmund Braun; Philipp Lange; Julia Riegger; Jerry Ware; Annekathrin Eckart; Selgai Haidari; Martina Rudelius; Christian Schulz; Katrin Echtler; Volker Brinkmann; Markus Schwaiger; Klaus T Preissner; Denisa D Wagner; Nigel Mackman; Bernd Engelmann; Steffen Massberg
Journal:  J Exp Med       Date:  2012-03-26       Impact factor: 14.307

10.  Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis.

Authors:  Daniel Myers; Diana Farris; Angela Hawley; Shirley Wrobleski; Amy Chapman; Lloyd Stoolman; Randy Knibbs; Robert Strieter; Thomas Wakefield
Journal:  J Surg Res       Date:  2002-12       Impact factor: 2.192

View more
  6 in total

1.  The association of venous thromboembolism chemoprophylaxis timing on venous thromboembolism after major vascular surgery.

Authors:  Danielle C Sutzko; Patrick E Georgoff; Andrea T Obi; Mark A Healy; Nicholas H Osborne
Journal:  J Vasc Surg       Date:  2017-09-01       Impact factor: 4.268

2.  TLR3 absence confers increased survival with improved macrophage activity against pneumonia.

Authors:  Madathilparambil V Suresh; Vladislav A Dolgachev; Boya Zhang; Sanjay Balijepalli; Samantha Swamy; Jashitha Mooliyil; Georgia Kralovich; Bivin Thomas; David Machado-Aranda; Monita Karmakar; Sanjeev Lalwani; Arulselvi Subramanian; Arun Anantharam; Bethany B Moore; Krishnan Raghavendran
Journal:  JCI Insight       Date:  2019-12-05

3.  Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia.

Authors:  Boya Zhang; Samantha Swamy; Sanjay Balijepalli; Sreehari Panicker; Jashitha Mooliyil; Matthew A Sherman; Jaakko Parkkinen; Krishnan Raghavendran; Madathilparambil V Suresh
Journal:  FASEB J       Date:  2019-09-17       Impact factor: 5.834

Review 4.  P- and E- selectin in venous thrombosis and non-venous pathologies.

Authors:  Megan Purdy; Andrea Obi; Daniel Myers; Thomas Wakefield
Journal:  J Thromb Haemost       Date:  2022-03-25       Impact factor: 16.036

5.  Sepsis-induced thrombus formation and cell-specific HIFs.

Authors:  Colin E Evans; Addie B Spier; You-Yang Zhao
Journal:  Thromb Res       Date:  2018-08-31       Impact factor: 3.944

Review 6.  Immune Factors in Deep Vein Thrombosis Initiation.

Authors:  Ivan Budnik; Alexander Brill
Journal:  Trends Immunol       Date:  2018-05-16       Impact factor: 16.687

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.